ACAD

ACADIA Pharmaceuticals Inc.

ACAD·004225108·US·Common Stock·Healthcare - Biotechnology-Activist

ACAD (ACADIA Pharmaceuticals Inc.) is held by 175 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($1.1B), BlackRock, Inc. ($569.6M), STATE STREET CORP ($229.6M). Net institutional sentiment: Mixed.

175
Holders
(14 Elite)
$3.9B
Total Value
54% (168)
Consensus
91 buying - 77 selling
13F: Insider & Congress: Updated regularly
ACAD

Smart Money Verdict

View all
Loading verdict
Held by 175 funds
14 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 7, 2026 · Activists Aug 7, 2026 · Congress none

ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.3%Aug 7, 2026
InsiderSCSchneyer Mark C.Sell $145KAug 6, 2026
InsiderSCSchneyer Mark C.Sell $273KAug 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
42.9M(+0.0%)$1.1B5.4%+7.60%
62
Increased
22.5M(+4.5%)$569.6M0.0%+67.89%
33
Increased
9.1M(+8.9%)$229.6M0.0%+17.08%
33
Increased
8.8M(+1.9%)$223.6M0.0%+31.16%
31
Unchanged
7.1M$180.8M1.5%+59.55%
0
Increased
5.8M(+1.8%)$145.8M0.0%+31.18%
31
Increased
3.7M(+17.1%)$93.5M0.0%+46.66%
35
Decreased
3.4M(-3.1%)$85M0.0%+12.49%
0
Increased
2.6M(+65.6%)$65.3M0.0%+41.23%
43
Increased
2.4M(+157.5%)$61.9M0.1%+21.63%
48
Decreased
2.4M(-5.6%)$61.6M0.1%+32.16%
0
Increased
2.2M(+250.4%)$55.2M0.0%+16.60%
47
Decreased
2M(-2.1%)$50.1M0.0%+32.64%
0
Increased
2M(+25.5%)$49.8M0.0%+32.69%
36
Increased
1.8M(+2216.5%)$44.7M0.0%+17.74%
47
Increased
1.7M(+132.7%)$43M0.0%+20.44%
47
Increased
1.4M(+7.5%)$34.6M0.0%+23.86%
31
Increased
1.3M(+30.0%)$34.1M0.0%+47.60%
36
Decreased
1.3M(-0.5%)$33.5M0.1%+31.47%
0
Decreased
1.3M(-16.3%)$32.9M0.0%+43.09%
0

Showing 1-20 of 180

1 / 9
ACADACADACADIA Pharmaceuticals Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used